PERSPECTIVES OF PRODUCTS FOR FUNCTIONAL NUTRITION IN CHILDREN
Abstract
Normal microflora of gastrointestinal tract provides colonization resistance of intestine, takes part in digestion, synthesis of vitamins and systemic stimulation of immune reactions. Prophylaxis of intestinal microbiocenosis disorders, their timely diagnostics and proper correction are significant for normalization of gastrointestinal function, formation of immune system and harmonious development of a child. There are several approaches to the regulation of intestinal micro biocenosis; the perspective one is diet with functional food containing prebiotic microorganisms. The article analyses data on physiological role of intestinal biocenosis, presents main standards of prebiotic strains. Modern studies show high clinical efficacy of Lactobacillus GG strain. This probiotic can be recommended in production of functional food for infants’ nutrition.
Key words: children, intestinal micro flora, probiotics, Lactobacillus GG.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2011; 10 (2): 150–154)
About the Authors
I.N. ZakharovaYu.A. Dmitriyeva
References
1. Orrhage К., Nord С.Е. Factors controling the bacterial colonisation of the intestine in breastfed infants. Acta Paediatr. 1999; 88(430): 47–57.
2. Fons M., Gomez A., Karjalainen T. Mechanisms of colonization and colonization resistance of the digestive tract. Microbial. Ecol. Health. Dis. 2000; 2: 242–246.
3. Урсова Н.И. Дисбактериозы кишечника у детей. Руководство для практикующих врачей. М. 2006. С. 8–38.
4. Englyst H.N., Hay S., Macfarlan G.T. Polysacchrides breakdown by mixed population of human fecal bacteria. FEMS Microbiol. Ecol. 1987; 95: 163–171.
5. Yaeshima T. Benefits of bifidobacteria to human health. Bulletin IDF. 1996; 313: 36–42.
6. Шендеров Б.А. Медицинская микробная экология и функциональное питание. М.: Грантъ. 1998. Т.1. 286 с.
7. Ардатская М.Д., Минушкин О.Н., Дубинин А.В. Дисбактериоз кишечника: современные аспекты изучения проблемы, принципы диагностики и лечения (обзор). Терапевтический архив. 2001; 2: 67–72.
8. Куваева И.Б. Обмен веществ организма и кишечная микpофлоpа. М.: Медицина. 1976; 228–246.
9. Cherbut C., Aube A.C., Blottiere H.M., Galmiche J.P. Effects of short-chain fatty acids on gastrointestinal motility. Scand. J. Gastroenterology. 1997; 32 (Suppl. 222): 58–61.
10. Fuller R. Probiotics in man and animals. J. Appl. Bacteriol. 1989; 66: 365–378.
11. Мазанкова Л.Н., Шевелева С.А., Лыкова Е.А. Клиническое применение пробиотиков: систематизация препаратов и тактика назначения в детском возрасте. Пособие для врачей. М. 2005. 27 с.
12. Walter J. The ecological role of lactobacilli in gastrointestinal tract: implications for fundamental and biomedical research. Appl. Environ. Microbiol. 2008; 74 (16): 4985–4996.
13. Goldin B.R., Gorbach S.L., Saxelin M. et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 1992; 37 (1): 121–128.
14. Canani R.B., Cirillo P., Terrin G. et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ. 2007; 335 (7615): 340.
15. Guandalini S., Pensabene L., Zikri M.A. et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 2000; 30 (1): 54–60.
16. Hojsak I., Abdović S., Szajewska H. et al. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics. 2010; 125 (5): 1171–1177.
17. McFarland L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am. J. Gastroenterol. 2006; 101 (4): 812–822.
18. Gawrońska A., Dziechciarz P., Horvath A., Szajewska H. A randomized double blind placebo controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment. Pharmacol. Ther. 2007; 25 (2): 177–184.
19. Francavilla R., Miniello V., Magistà A.M. et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010; 126 (6): 1445–1452.
20. Hatakka R., Savilahti E., Ponka A. et al. Effects of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomized trial. BMJ. 2001; 22 (7238): 1327.
21. Rautava S., Salminen S., Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy a randomised double blind, placebo-controlled study. Br. J. Nutr. 2009; 101(11): 1722–1726.
22. Kalliomaki M., Salminen S., Poussa T. et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in randomized placebo controlled trial. J. Allergy Clin. Immunol. 2007; 119 (4): 1019–1021.
23. Baldassarre M.E., Laforgia N., Fanelli M. et al. Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. J. Pediatr. 2010; 156 (3): 397–401.
24. Nermes M., Kantele J.M., Atosuo T.J. et al. Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin. Exp. Allergy. 2011; 41 (3): 370–377.
25. Näse L., Hatakka K., Savilahti E. et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001; 35 (6): 412–420.
Review
For citations:
Zakharova I., Dmitriyeva Yu. PERSPECTIVES OF PRODUCTS FOR FUNCTIONAL NUTRITION IN CHILDREN. Current Pediatrics. 2011;10(2):150-154.
Email this article 
